A. V. Nikishina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
A. V. Nikishina has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Ivan S. Ignatov
I.M. Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications - Petr V. Tsarkov
I.M. Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications - Vladimir Balaban
I.M. Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications - A. N. Stetsyuk
Department of Oncology, Radiotherapy and Reconstructive Surgery, Levshin Institute of Cluster Oncology, Sechenov First Moscow State Medical University, 119435 Moscow, Russia
1 shared publication - Evgenii A. Bezrukov
Clinic of Proctology and Minimally Invasive Surgery of I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
1 shared publication - Inna A. Tulina
I.M. Sechenov First Moscow State Medical University (Sechenov University)
1 shared publication
Latest Publications
- Open Access
- 30 November 2025
- Published by Russian Gastroenterolgocial Society in Russian Journal of Gastroenterology, Hepatology, Coloproctology
- Vol. 35 (5) , 100-111
A Case Series of Prostate Cancer Metastases to the Sigmoid Mesocolon in Patients with Colorectal Cancer
This article presents three rare clinical cases of prostate cancer metastasis to the mesosigmoid lymph nodes in patients with primary multiple prostate and sigmoid colon cancer. We were able to find descriptions of only three similar cases in international literature. In all cases, the source of metastasis was confirmed by immunohistochemistry: expression of prostate biomarkers and the absence of expression of intestinal adenocarcinoma markers were detected. Furthermore, we describe a case of the so-called “collision phenomenon” in one of the lymph nodes. The detection of prostate cancer metastases to the mesocolic region demonstrates the interconnection between the lymphatic collectors of the colon and the prostate gland. Therefore, it is important to conduct a thorough pathological examination of the surgical specimen, and in ambiguous cases, immunohistochemistry is indicated for accurate diagnosis and treatment planning. Further studies are needed to investigate the relationship between lymphatic drainage pathways from the prostate and distal colon.
- 30 November 2025
- Published by Russian Gastroenterolgocial Society in Russian Journal of Gastroenterology, Hepatology, Coloproctology
- Vol. 35 (5) , 100-111
Open AccessA Case Series of Prostate Cancer Metastases to the Sigmoid Mesocolon in Patients with Colorectal Cancer
This article presents three rare clinical cases of prostate cancer metastasis to the mesosigmoid lymph nodes in patients with primary multiple prostate and sigmoid colon cancer. We were able to find descriptions of only three similar cases in international literature. In all cases, the source of metastasis was confirmed by immunohistochemistry: expression of prostate biomarkers and the absence of expression of intestinal adenocarcinoma markers were detected. Furthermore, we describe a case of the so-called “collision phenomenon” in one of the lymph nodes. The detection of prostate cancer metastases to the mesocolic region demonstrates the interconnection between the lymphatic collectors of the colon and the prostate gland. Therefore, it is important to conduct a thorough pathological examination of the surgical specimen, and in ambiguous cases, immunohistochemistry is indicated for accurate diagnosis and treatment planning. Further studies are needed to investigate the relationship between lymphatic drainage pathways from the prostate and distal colon.
- Open Access
- 30 December 2024
- Published by Russian Gastroenterolgocial Society in Russian Journal of Gastroenterology, Hepatology, Coloproctology
- Vol. 34 (6) , 49-66
Outcomes of Surgical Treatment of Multiple Primary Colorectal and Prostate Cancer
Aim: to evaluate the outcomes of surgical treatment of patients with multiple primary cancer of the colon and prostate.Materials and methods. An observational retrospective study was conducted at the Clinic of Coloproctology and Minimally Invasive Surgery (I.M. Sechenov First Moscow State Medical University). A total of 3,640 protocols of the preoperative multidisciplinary team were studied from July 2018 to April 2024. The inclusion criterion was the diagnosis of multiple colorectal and prostate cancer. The medical documentation was collected in the database and analyzed.Results. The study included 39 patients: 24 patients with a metachronous variant of multiple primary cancer and 15 patients with a synchronous variant of the disease, which amounted to 1.1 % of all patients who underwent a preoperative consultation during the specified period. There were no significant differences in age, localization of tumors in the colon, methods of their treatment, access in surgical treatment of colorectal cancer, frequency of conversions and postoperative complications (p > 0.05). Prostate cancer was verified first in the group with the metachronous variant of multiple primary cancer significantly more often than in the group with the synchronous variant (95.8 % vs. 40.0 %, respectively; p < 0.001), and was also significantly more often treated surgically (75.0 % vs. 33.3 %; p = 0.018). Radical prostatectomy was performed via laparotomy significantly less frequently in the group with the synchronous variant than in the group with the metachronous cancer (0 % vs. 58.8 %; p = 0.046). No significant differences were found when comparing overall and recurrence-free survival in groups with metachronous and synchronous variants of multiple primary cancer.Conclusions. A clinician should be alert to multiple primary colorectal and prostate cancer. The first stage of therapy for the synchronous variant should be surgical treatment of colorectal cancer. The history of surgical treatment of one of the tumors is not a contraindication for the use of minimally invasive techniques, however, the choice of surgical approach should be individualized. The presence of prostate cancer may be another factor in favor of performing lateral lymph node dissection in patients with synchronous rectal cancer.
- 30 December 2024
- Published by Russian Gastroenterolgocial Society in Russian Journal of Gastroenterology, Hepatology, Coloproctology
- Vol. 34 (6) , 49-66
Open AccessOutcomes of Surgical Treatment of Multiple Primary Colorectal and Prostate Cancer
Aim: to evaluate the outcomes of surgical treatment of patients with multiple primary cancer of the colon and prostate.Materials and methods. An observational retrospective study was conducted at the Clinic of Coloproctology and Minimally Invasive Surgery (I.M. Sechenov First Moscow State Medical University). A total of 3,640 protocols of the preoperative multidisciplinary team were studied from July 2018 to April 2024. The inclusion criterion was the diagnosis of multiple colorectal and prostate cancer. The medical documentation was collected in the database and analyzed.Results. The study included 39 patients: 24 patients with a metachronous variant of multiple primary cancer and 15 patients with a synchronous variant of the disease, which amounted to 1.1 % of all patients who underwent a preoperative consultation during the specified period. There were no significant differences in age, localization of tumors in the colon, methods of their treatment, access in surgical treatment of colorectal cancer, frequency of conversions and postoperative complications (p > 0.05). Prostate cancer was verified first in the group with the metachronous variant of multiple primary cancer significantly more often than in the group with the synchronous variant (95.8 % vs. 40.0 %, respectively; p < 0.001), and was also significantly more often treated surgically (75.0 % vs. 33.3 %; p = 0.018). Radical prostatectomy was performed via laparotomy significantly less frequently in the group with the synchronous variant than in the group with the metachronous cancer (0 % vs. 58.8 %; p = 0.046). No significant differences were found when comparing overall and recurrence-free survival in groups with metachronous and synchronous variants of multiple primary cancer.Conclusions. A clinician should be alert to multiple primary colorectal and prostate cancer. The first stage of therapy for the synchronous variant should be surgical treatment of colorectal cancer. The history of surgical treatment of one of the tumors is not a contraindication for the use of minimally invasive techniques, however, the choice of surgical approach should be individualized. The presence of prostate cancer may be another factor in favor of performing lateral lymph node dissection in patients with synchronous rectal cancer.